Actavis Puts Up $8.5B For Warner Chilcott
Actavis Inc. will acquire Ireland-based Warner Chilcott PLC, inking a $8.5 billion deal that expands its clout in generic specialty medicine by creating a new trans-Atlantic pharmaceutical giant, Actavis announced Monday....To view the full article, register now.
Already a subscriber? Click here to view full article